Pharma stocks explode as investors prepare for litigation fees
shares GlaxoSmithKlineAnd the Sanofi And the halon They all sold off sharply this week, losing tens of billions of market value, as investors feared potential US litigation fees focused on the popular heartburn drug Zantac. This has been a known issue bouncing around in the background for years, but investor anxiety exploded this week in … Read more